Press Releases

12345678910
AECOM awarded nationwide U.S. Department of Homeland Security contract to support critical infrastructure modernization
AECOM (NYSE: ACM), the trusted global infrastructure leader, today announced it has been selected to continue providing architecture and engineering (A/E) services to the U.S. Department of Homeland Security (DHS) for its critical infrastructure modernization initiatives. Under this contract, AECOM will support mission-critical renovations and upgrades for government facilities across all 50 U.S. states, as well as Puerto Rico, Guam and the U.S. Virgin Islands.
By AECOM · Via Business Wire · June 8, 2026
SUNation Energy and Suniva Enter Definitive Merger Agreement, Creating a Platform for American Solar Manufacturing and Services Leadership
Combined company to accelerate Suniva’s U.S. solar cell manufacturing expansion and market leadership, backed by SUNation's established market presence, deep end-market relationships, and Nasdaq-listed platform 
By SUNation Energy, Inc. · Via GlobeNewswire · June 8, 2026
MixRoute Expands AI Gateway Features to Address Rising API Rate-Limit Challenges
Singapore, Singapore--(Newsfile Corp. - June 8, 2026) - MixRoute, an AI API gateway platform, has introduced new traffic management and...
Via Newsfile · June 8, 2026
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for HYMPAVZI® (marstacimab-hncq) to include the treatment of patients with hemophilia A or B 12 years and older with inhibitors and pediatric patients (ages 6 to 11 years) with or without inhibitors. HYMPAVZI is now indicated in the U.S. for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 6 years of age and older with hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors, or hemophilia B (congenital factor IX deficiency) with or without factor IX inhibitors.
By Pfizer Inc. · Via Business Wire · June 8, 2026
EDUFORM'ACTION : VISIO CONFÉRENCE dédiée aux actionnaires individuels et aux investisseurs
Via Actus News · June 8, 2026
Bullish releases May 2026 monthly metrics
Bullish (NYSE: BLSH), an institutionally focused global digital asset platform that provides market infrastructure and information services, released its monthly metrics for May 2026 on Monday, June 8, 2026.
By Bullish · Via Business Wire · June 8, 2026
Zedge Provides Shareholder Update on Capital Return Initiatives
Adds $2 Million to Existing Class B Common Stock Repurchase Authorization;
Via ACCESS Newswire · June 8, 2026
Intelligent Protection Management Corp. to Participate in "Architecting Tomorrow: The AI Data Center Summit" Presented by Maxim Group LLC on Thursday, June 11th at 10:30 a.m. ET
JERICHO, NY / ACCESS Newswire / June 8, 2026 / Intelligent Protection Management Corp. ("IPM," "we," "us," "our" or the "Company") (NASDAQ:IPM), a managed technology solutions provider focused on enterprise cybersecurity and cloud infrastructure, announced today that Jason Katz, CEO, has been invited to present at the "Architecting Tomorrow: The AI Data Center Summit" presented by Maxim Group LLC, on Thursday, June 11th at 10:30 a.m. ET.
Via ACCESS Newswire · June 8, 2026
AstroNova Reports 4.4% Growth in Sales for First Quarter Fiscal 2027
AstroNova, Inc. (Nasdaq: ALOT), a leading innovator in specialized print technology solutions, today announced financial results for its fiscal 2027 first quarter ended April 30, 2026.
By AstroNova, Inc. · Via Business Wire · June 8, 2026
LibertyStream Announces Lithium Carbonate Offtake Milestone with U.S. Industrial Customer and Provides Operations Update
LibertyStream Infrastructure Partners Inc. (TSXV: LIB | OTCQB: VLTLF | FSE: I2D) (“LibertyStream” or the “Company”) has executed a term sheet containing material terms for a long-term lithium carbonate offtake agreement with a leading American industrial customer (the “Offtake Partner”). The parties expect to finalize and enter into a definitive arrangement (the “Offtake Agreement”) within 30 days of this announcement.
NUBURU Files Golden Power Notification for Majority Acquisition of Tekne, Launching Formal Review by the Italian Government
NUBURU, Inc. (NYSE American: BURU), the next-generation dual-use Defense & Security integrated platform company focused on non-kinetic effects and directed-energy technologies, electronic warfare and defense mobility programs, software-orchestrated defense systems, and advanced manufacturing, today announced that NUBURU and NUBURU Defense LLC have submitted the Golden Power notification to the Italian Government in connection with NUBURU's planned acquisition of a controlling 70% ownership stake in Tekne S.p.A. ("Tekne").
By NUBURU, Inc. · Via Business Wire · June 8, 2026
Babcock & Wilcox to Support TerraSpark’s Development Efforts for 1.6 GW Coal-fired Power Plant Project in West Virginia
Babcock & Wilcox (B&W) (NYSE: BW) today announced it is collaborating with TerraSpark in support of its planned energy generation project in West Virginia. The project, known as the TerraSpark Energy Campus, will include a 1.6-gigawatt (GW) coal-fired power plant, a multi-industry campus and a Coal Innovation & Training Center for rare earth extraction and advanced materials initiatives. The project has been awarded an $18.5 million grant from the U.S. Department of Energy to support its development.
Trane Technologies Scales Sustainability Through Climate Innovation, Circularity and Workforce Development
Trane Technologies (NYSE: TT), a global climate innovator, is advancing sustainable and energy-efficient solutions for buildings, industry and the cold chain while continuing to strengthen its own operations. Through electrification, digital innovation and circular strategies, the company is helping customers improve efficiency, reduce emissions, lower operating costs and build resilience.
By Trane Technologies · Via Business Wire · June 8, 2026
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries, today introduced Deora™, a new proprietary pen injector platform targeting incretin-based therapies, as well as supporting other originator and biosimilar drug development programs.
By Stevanato Group · Via Business Wire · June 8, 2026
New Analysis Strengthens Mercator Gold System and Confirms High-Grade BIF Continuity
Approximately 82% of the 111 high-resolution samples returned gold values above detection limits, supporting the continuity of mineralization across multiple drill intercepts and target zones
By Canadian GoldCamps Corp. · Via GlobeNewswire · June 8, 2026
Red White & Bloom Brands' Subsidiary, Emblem Cannabis Corporation, Completes Acquisition of Ayurcann's Health Canada-Licensed Manufacturing Operations, Leading Vape & Pre-Roll Brands, and Expanded National Distribution Capabilities
Emblem Cannabis Corporation completes acquisition of Ayurcann Inc. in a Court-supervised CCAA sale process
Parsons Marks Groundbreaking of Major Interchange Improvements Project in Connecticut
CHANTILLY, Va., June 08, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) recently joined the Connecticut Department of Transportation (CTDOT), federal partners, and community leaders to mark the groundbreaking of the I-91/I-691/Route 15 Interchange Improvements Project in Meriden, Connecticut.
By Parsons Services Company · Via GlobeNewswire · June 8, 2026
Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today
SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases, today highlighted clinical, safety and translational data for AlloNK (also known as AB-101), an allogeneic, off-the-shelf, non-genetically modified natural killer (NK) cell therapy candidate, presented at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress in London.
Volato Group Announces $2.2 Million Strategic Investment and AI Infrastructure Acquisition Focus
Volato Group, Inc. (NYSE American: SOAR) (the “Company” or “Volato”), a technology company focused on building scalable software and data solutions that improve the reliability and intelligence of high-stakes business decisions, today announced the signing of a definitive agreement to obtain a $2.2 million strategic investment lead by Catheter Precision, Inc. (NYSE American: VTAK), and other institutional investors with experience investing in artificial intelligence and emerging technology companies.
By Volato Group, Inc. · Via Business Wire · June 8, 2026
Black Castle Capital Partners Celebrates Successful Launch of Kabuni Sports at PLAYTIME 2026 in Mumbai
AI-powered PlayOS, revolutionary K10 physical esport and Kabuni Premier League unveiled at landmark PLAYTIME 2026 showcase
Printblur Spotlights "Dad Lore" as a More Personal Way to Think About Father's Day Gifts
Derry, New Hampshire--(Newsfile Corp. - June 8, 2026) - Printblur is spotlighting "Dad Lore" as a gifting idea built around...
Via Newsfile · June 8, 2026
Nefense Advances Airway Hygiene with Hypochlorous Acid Nasal Spray
Dubuque, Iowa--(Newsfile Corp. - June 8, 2026) - Nefense®, a...
Via Newsfile · June 8, 2026
Founder Taylor Shien Expands DermaClear Skin's Consumer Education Initiative
Atlanta, Georgia--(Newsfile Corp. - June 8, 2026) - DermaClear Skin announced plans to expand its consumer education initiatives as the...
Via Newsfile · June 8, 2026
Ridge Security Launches RidgeBot 7.0 with Fully Automated Active Directory Penetration Testing
Ridge Security, leader in AI-powered offensive security and Continuous Threat Exposure Management (CTEM), today announced the release of RidgeBot 7.0, a major advancement in automated security validation, that introduces fully automated Windows Active Directory penetration testing capabilities. This latest version of RidgeBot enables organizations to conduct comprehensive end-to-end domain compromise simulations, helping security teams validate real-world attack paths and prioritize exploitable risks with greater precision.
By Ridge Security · Via Business Wire · June 8, 2026
Token Appoints Dianne Liu as Vice President of Marketing
Token, the biometric identity assurance company, announced the appointment of Dianne Liu as Vice President of Marketing. Liu will lead Token’s marketing organization, building the demand engine and market narrative behind TokenCore as the company scales the category it created – Cryptographic Biometric Identity Assurance – into the AI era.
By Token · Via Business Wire · June 8, 2026
Volta Intersects 0.81% Total Rare Earth Oxide and 68.13 g/t Gallium Oxide over 688m at Springer REE Project in Ontario, Canada
HIGHLIGHTSSL26-35 contains the longest REE-Ga mineralized interval to date at Springer.Gallium and Rare Earth Elements are designated critical minerals by...
Via Newsfile · June 8, 2026
OS Therapies Achieves Global Regulatory Alignment on Design of Phase 3 Trial of OST-HER2 in Fully Resected, Pulmonary Metastatic Osteosarcoma
Confirmatory Phase 3 trial to commence prior to BLA grant under Accelerated Approval Program in the U.S. and Conditional MAA...
Via Newsfile · June 8, 2026
Mitsubishi Electric and Semikron Danfoss Jointly Develop New Standard Package for Power Semiconductor Modules
Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has jointly developed a new standard package for power modules with integrated 3-level circuits, designed for industrial drive equipment and renewable energy systems, in collaboration with Semikron Danfoss Elektronik GmbH & Co. KG, a leading global manufacturer of power semiconductors.
Car Connectivity Consortium Advances Digital Key Version 4 Testing at Plugfest #18
The Car Connectivity Consortium (CCC), the trusted source for defining how vehicles interact with devices and the world through standardized, secure, and convenient connectivity solutions, is hosting its 18th end-to-end interoperability Plugfest this week at the automotive test center of DEKRA Lausitzring in Germany, bringing together leading automakers, device manufacturers, test equipment providers, and laboratories to advance testing and validation of CCC Digital Key™ implementations.
By Car Connectivity Consortium · Via Business Wire · June 8, 2026
Twenty One Capital Appoints Independent Director to Board
Twenty One Capital, Inc. (“Twenty One” or “XXI”) today announced the appointment of Paul S. Lalljie as an independent director to its Board of Directors. Lalljie will also serve as a member of the Board’s audit committee.
By Twenty One Capital, Inc. · Via Business Wire · June 8, 2026
Enigmatig Limited Issues Statement on Recent Share Trading Activity
SINGAPORE, June 08, 2026 (GLOBE NEWSWIRE) -- Enigmatig Limited (NYSE American: EGG) (“Enigmatig” or the “Company”), a global business enabler supporting companies expanding across borders, today announced that the Company issued the following statement in accordance with Section 401(d) of the NYSE American Company Guide regarding recent trading activity in its ordinary shares on June 4 and 5, 2026.
By Enigmatig Ltd · Via GlobeNewswire · June 8, 2026
Cresco Labs Closes US$50 Million Revolving Credit Facility with Needham Bank
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”) today announced the closing of a credit agreement with Needham Bank, a Massachusetts-based commercial bank, providing the Company with a US$50 million revolving credit facility (the “Facility”).
By Cresco Labs · Via Business Wire · June 8, 2026
Famous Brands International Appoints Richard Screnci as Executive Director
Famous Brands International ("Famous Brands"), the franchising business behind globally recognized brands Mrs. Fields® and TCBY®, today announced the appointment of Richard Screnci as Executive Director.
By Famous Brands International · Via Business Wire · June 8, 2026
Shattuck Labs Announces Phase 1 Results for SL-325
AUSTIN, TX and DURHAM, NC, June 08, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potential first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced data from its Phase 1 clinical trial of SL-325, Shattuck’s lead DR3 blocking antibody candidate.
By Shattuck Labs, Inc. · Via GlobeNewswire · June 8, 2026
Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy
Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics. Shilpa becomes a strategic shareholder and CMC, manufacturing, and regulatory partner for G2B-002 — Gate2Brain's lead program targeting deadly pediatric brain cancers, DIPG and pGBM, both with Orphan Drug Designation from the US FDA and EMA. G2B-002 uses Gate2Brain's proprietary MiniAp4 peptide shuttle to deliver SN-38 across the blood-brain barrier, demonstrating up to 100-fold greater brain drug transport preclinically. First-in-human trials are anticipated by FY28.
By Shilpa Medicare Ltd · Via Business Wire · June 8, 2026
Lixiang Education Regains Compliance with Nasdaq Minimum Market Value of Publicly Held Shares Requirement
LISHUI, China, June 08, 2026 (GLOBE NEWSWIRE) -- Lixiang Education Holding Co., Ltd. (the “Company” or NASDAQ: LXEH), a prestigious private education service provider in China, today announced that on June 5, 2026, it received a letter from the Listing Qualification Department of Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for at least the 10 consecutive business days, from May 21, 2026 to June 4, 2026, the Company’s minimum market value of publicly held shares (“MVPHS”) has been US$5,000,000 or greater. Accordingly, the Company has regained compliance with Listing Rule 5450(b)(1)(C), and this matter is now closed.
MEXC SPACEX(PRE) Launchpad Subscriptions Exceed $173M Across Two Phases
By MEXC · Via GlobeNewswire · June 8, 2026
Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion
SOUTH SAN FRANCISCO, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today provided an update on the safety profile of LYL273 in its ongoing U.S. Phase 1 clinical trial in patients with relapsed or refractory metastatic colorectal cancer (mCRC), and announced the Phase 1 trial has been amended to enable seamless expansion into a potential pivotal single-arm Phase 2 trial pending regulatory alignment.
By Lyell Immunopharma, Inc · Via GlobeNewswire · June 8, 2026
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
MINNEAPOLIS and BRISBANE, Australia, June 08, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) announced today that it has received full regulatory clearance from the French National Agency for Medicines and Health Products Safety (ANSM) for the DurAVR® Transcatheter Heart Valve (THV) global pivotal trial in patients with severe calcific aortic stenosis (the “PARADIGM Trial”). This authorization marks a significant milestone in the Company’s clinical and regulatory strategy and enables patient recruitment to commence at leading centers in France.
Pre-Feasibility Study for Grey Fox at Fox Complex — High Returns, Manageable Capital, Mine Life Extended to 2041
TORONTO, June 08, 2026 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE, TSX: MUX) (“McEwen” or the “Company”) is pleased to announce the results of the Pre-Feasibility Study (“PFS”) for its 100%-owned Grey Fox Project, located near Timmins, Ontario. Grey Fox is expected to become a major source of ore for the Fox Complex and play a key role in increasing production. With the addition of Grey Fox, gold production at the Fox Complex is projected to reach ~100,000 gold ounces in 2029 and average ~87,000 gold ounces annually from 2028 through 2041. This production growth is expected to support the Company's near-term objective of increasing total annual production to 250,000–300,000 gold equivalent ounces ("GEOs") by 2030.
By McEwen Inc. · Via GlobeNewswire · June 8, 2026
American Battery Technology Company Wins Appeal and Has US Department of Energy Grant Reinstated for $115 million Project for Commercial Scale Critical Mineral Lithium Refinery
Reno, Nev., June 08, 2026 (GLOBE NEWSWIRE) --
Tebbit Exchange: Engineering Trust and Performance in the Digital Asset Era
As global digital finance enters a new phase of maturity and disruption, Tebbit Exchange stands at the forefront — combining
Via First Publisher · June 8, 2026
Upriver Raises $14M to Automate the Enterprise Data Foundation for AI
With backing from Hetz Ventures and Valley Capital Partners, the company is automating the data engineering work that has prevented enterprise AI initiatives from reaching production, and delivering real ROI.
Via ACCESS Newswire · June 8, 2026
Family-Owned Simply Beef Jerky Introduces a Premium Take on Traditional Beef Jerky
Hollywood, Florida--(Newsfile Corp. - June 8, 2026) - Simply Beef Jerky is introducing a premium approach to traditional beef jerky...
Via Newsfile · June 8, 2026
Completes Arctic Scientific Expedition Field Test! DEEP Robotics' Robot Dog Conquers Another Extreme Scenario
AKUREYRI, IS / ACCESS Newswire / June 8, 2026 / The research vessel Sun Yat-sen University Polar is a pioneering polar scientific research vessel independently owned and operated by a university. Not long ago, it completed its second Arctic Ocean expedition, lasting 76 days, covering a total voyage of 11,852 nautical miles, and reaching a northernmost latitude of 81.6°N. A team of 38 faculty and students from 13 universities and research institutes collected ice samples and various precious scientific research specimens and data from the Arctic Ocean, providing crucial scientific support for a deeper understanding of the air-ice-sea interactions and environmental change mechanisms in the Arctic. A prototype of DEEP Robotics' small wheeled-legged robot, the Lynx S10, also accompanied the vessel, conducting multiple extreme environment performance tests on Arctic Ocean ice floes and in icy waters - marking the first time a quadruped robot has stepped onto the surface of the Arctic Ocean.
Via ACCESS Newswire · June 8, 2026
Interpath Global Expands Veterinary Focus Following Strong Growth of 4CYTE™
Interpath Global is expanding its investment in veterinary education and industry engagement following the successful launch and continued growth of 4CYTE™ Epiitalis® Forte Dog.
By Interpath Global · Via Business Wire · June 8, 2026
GEN Restaurant Group Secures Retail Placement at Save Mart Supermarkets with Six SKU Launch
CERRITOS, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), operator of GEN Korean BBQ, one of the largest full-service Korean BBQ restaurant chains in the United States, today announced that its consumer packaged goods products have been accepted for retail placement at Save Mart Supermarkets, a leading regional grocery chain across California and Nevada. GEN will launch six SKUs across all Save Mart store locations, with each location initially stocking one case per SKU.
By GEN Restaurant Group, Inc. · Via GlobeNewswire · June 8, 2026
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China, Strengthen Presence in Ophthalmology
By Everest Medicines Limited · Via ACN Newswire · June 8, 2026
Haleon Invests in India to Deliver Better Everyday Health to Rural Communities
Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia.
By Haleon · Via Business Wire · June 8, 2026
Transaction in Own Shares
Transaction in Own Shares
By Shell plc · Via GlobeNewswire · June 8, 2026